Incidence of intravenous catheter-site complications in patients treated with linezolid or vancomycin for skin infections caused by methicillin- resistantStaphylococcus aureus

Hospital Pharmacy

Volumn 46, Issue 6, 2011, Pages 427-431

  Luke, David ^a   Hewlett Jr , Dial ^a   Welch, Verna ^a   Chambers, Richard ^a   Huang, David ^a  

^a PFIZER INC   (United States)

Author keywords

catheter site infection; linezolid; MRSA; skin and skin structure infections; vancomycin

Indexed keywords

LINEZOLID; VANCOMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; CATHETER COMPLICATION; DEMOGRAPHY; DRUG ERUPTION; DRUG WITHDRAWAL; ERYTHEMA; ESCHERICHIA COLI INFECTION; HUMAN; INFUSION SITE ERYTHEMA; INFUSION SITE THROMBOSIS; INTRAVENOUS CATHETER SITE COMPLICATION; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; PASTEURELLOSIS; PHLEBITIS; POST HOC ANALYSIS; SEPSIS; SKIN INFECTION; SKIN STRUCTURE; STAPHYLOCOCCUS INFECTION; THROMBOSIS; TREATMENT DURATION;

EID: 79958144492     PISSN: 00185787     EISSN: 19451253     Source Type: Journal    
DOI: 10.1310/hpj4606-427     Document Type: Article

References (21)

1. Tager IB, Ginsberg MB, Ellis SE, et al. An epidemiological study of the risks associated with peripheral intravenous catheters. Am J Epidemiol. 1983;118:839-851. (Pubitemid 14218764)
2. Tjon JA, Ansani NT. Transdermal nitroglycerin for the prevention of intravenous infusion failure due to phlebitis and extravasation. Ann Pharmacother. 2000;34:1189-1192.
3. Waitt C, Waitt P, Pirmohamed M. Intravenous therapy. Postgrad Med J. 2004;80:1-6. (Pubitemid 38221873)
4. Maki DG, Ringer M. Risk factors for infusion-related phlebitis with small peripheral venous catheters. Ann Intern Med. 1991;114:845-854.
5. Webster J, Clarke S, Paterson D, et al. Routine care of peripheral intravenous catheters versus clinically indicated replacement: randomised controlled trial. BMJ. 2008;337:a339.
6. Monreal M, Quilez F, Rey-Joly C, Rodriguez S, Sopena N, Neira C, Roca J. Infusion phlebitis in patients with acute pneumonia: a prospective study. Chest. 1999;115:1576-1580. (Pubitemid 29275647)
7. O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. MMWR. August 9, 2002;51(RR10):1-26. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5110a1.htm. Accessed October 1, 2010.
8. Breen JO.. Skin and soft tissue infections in immunocompetent patients. Am Fam Physician. 2010;1:893-899.
9. Roszell S, Jones C. Intravenous administration issues: a comparison of intravenous insertions and complications in vancomycin versus other antibiotics. J Infus Nurs. 2010;33:112-118.
10. Rezai K, Madariaga M, Thomas-Gossain N, Tenorio A, Segreti J. Complications of outpatient intravenous antibiotic therapy. Presented at the 43rd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy; September 13-17, 2003; Chicago, IL. Poster K-1428.
11. Hadaway L, Chamallas SN. Vancomycin: new perspectives on an old drug. J Infus Nurs. 2003;26:278-284. (Pubitemid 37328960)
12. Weigelt J, Itani K, Stevens D, Lau W, Dryden M, Knirsch C; Linezolid cSSTI Study Group. Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections. Antimicrob Agents Chemother. 2005;49:2260-2266. (Pubitemid 40734452)
13. Itani KMF, Dryden MS, Bhattacharyya H, Kunkel MJ, Baruch AM, Weigelt JA. Efficacy and safety of linezolid versus vancomycin for the treatment of complicated skin and softtissue infections proven to be caused by methicillin-resistant Staphylococcus aureus. Am J Surg. 2010;199:804-816.
14. Richet H, Hubert B, Nitemberg G, et al. Prospective multicenter study of vascular-catheter-related complications and risk factors for positive central-catheter cultures in intensive care unit patients. J Clin Microbiol. 1990;28:2520-2525. (Pubitemid 20353533)
15. Centers for Disease Control and Prevention. National nosocomial infections surveillance (NNIS) system report, data summary from January 1992 through June 2004. Am J Infect Control. 2004;32:470-485.
16. Maki DG, Kluger DM, Crnich CJ. The risk of bloodstream infection in adults with different intravascular devices: a systemic review of 200 published prospective studies. Mayo Clin Proc. 2006;81:1159-1171. (Pubitemid 44316281)
17. Cicalini S, Palmieri F, Petrosillo N. Clinical review: new technologies for prevention of intravascular catheter-related infections. Crit Care. 2004;8:157-162. (Pubitemid 38735694)
18. Bregenzer T, Conen D, Sakmann P, Widmer AF. Is routine replacement of peripheral intravenous catheters necessary? Arch Intern Med. 1998;158:151-156. (Pubitemid 28049508)
19. Rello J, Ochagavia A, Sabanes E, Roque M, Mariscal D, Reynaga E, Valles J. Evaluation of outcome of intravenous catheter-related infections in critically ill patients. Am J Respir Crit Care Med. 2000;162:1027-1030.
20. Dimick JB, Pelz RK, Consunji R, Swoboda SM, Hendrix CW, Lipsett PA. Increased resource use associated with catheter-related blood-stream infection in the surgical intensive care unit. Arch Surg. 2001;136:229-234. (Pubitemid 32143849)
21. McCollum M, Sorensen SV, Liu LZ. A comparison of costs and hospital length of stay associated with intravenous/oral linezolid or intravenous vancomycin treatment of complicated skin and soft-tissue infections caused by suspected or confirmed methicillin-resistant Staphylococcus aureus in elderly US patients. Clin Ther. 2007;29:469-477. (Pubitemid 46907284)